Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Update: Availability of Streptomycin and Para-Aminosalicylic Acid -- United States

Since April 1992, streptomycin (SM) and para-aminosalicylic acid (PAS) (antimicrobial agents used in the treatment of tuberculosis (TB)) have been available through CDC under an investigational new drug agreement for the treatment of patients with multidrug-resistant TB. SM will now be made available for use in the drug-treatment regimen of any patient with active TB. This announcement updates and supersedes the previous notice (1) on availability of SM. Eligibility criteria for PAS remain unchanged. Clinicians interested in obtaining SM or PAS for their patients should provide an abbreviated medical history and, for SM, a recent creatinine serum level measurement.

These drugs are expected to become commercially available in the United States later this year. Until then, requests should be directed to CDC's Clinical Research Branch, Division of Tuberculosis Elimination, National Center for Prevention Services; telephone (404) 639-2530.

Reference

  1. CDC. Availability of streptomycin and para-aminosalicylic acid -- United States. MMWR 1992;41:243

Disclaimer   All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Page converted: 08/05/98

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services

This page last reviewed 5/2/01